Bruker DRX

Bruker DRX is a high-performance nuclear magnetic resonance (NMR) spectrometer designed for detailed molecular structure analysis across various scientific disciplines. Introduced in the late 1990s, this instrument has been pivotal in advancing research methodologies.

Key features include:

• Versatile Probe Options: Accommodates multiple probe types, such as the 5 mm QNP probe for direct detection of nuclei like ¹H, ¹³C, ³¹P, and ¹⁵N, and the 5 mm z-gradient BBI probe for inverse detection, tunable to nuclei including ²⁰⁵Tl and ²⁰⁹Bi.

• Variable Temperature Control: Supports experiments across a wide temperature range, from -150°C to +150°C, facilitating studies of temperature-dependent molecular behaviours.

• High Sensitivity and Resolution: Equipped with advanced electronics and probe technology, the system delivers exceptional data quality, essential for complex molecular analyses.

• Multinuclear Capability: Enables the study of a broad spectrum of nuclei, enhancing its applicability in diverse research areas.

The Bruker DRX has been instrumental in fields such as biotechnology, pharmaceutical research, organic chemistry, and materials science. Its applications range from elucidating protein structures and studying nucleic acids to analysing complex organic compounds and novel materials.

Commonly utilised in university laboratories, biomedical research centres, and pharmaceutical companies, the Bruker DRX has significantly contributed to scientific advancements. Although Bruker discontinued the DRX series in 2002, with service support ending in 2016, many units remain operational in laboratories worldwide, underscoring their enduring reliability and performance.